Talkspace (TALK)
Market Price (3/6/2026): $4.8 | Market Cap: $797.7 MilSector: Health Care | Industry: Health Care Technology
Talkspace (TALK)
Market Price (3/6/2026): $4.8Market Cap: $797.7 MilSector: Health CareIndustry: Health Care Technology
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -12% | Trading close to highsDist 52W High is -4.2%, Dist 3Y High is -4.2% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -0.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms. | Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 110x, P/EPrice/Earnings or Price/(Net Income) is 187x | |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 62% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.8% | ||
| Key risksTALK key risks include [1] challenges in maintaining and expanding its network of therapists, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -12% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms. |
| Trading close to highsDist 52W High is -4.2%, Dist 3Y High is -4.2% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -0.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1% |
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 110x, P/EPrice/Earnings or Price/(Net Income) is 187x |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 62% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.8% |
| Key risksTALK key risks include [1] challenges in maintaining and expanding its network of therapists, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Strong Q4 2025 Financial Performance and Upbeat 2026 Guidance.
Talkspace reported robust fourth-quarter 2025 results on February 19, 2026, exceeding analyst expectations. The company announced an EPS of $0.03, beating consensus estimates of $0.02, and quarterly revenue of $63 million, surpassing estimates of $61.91 million. This represented a 29% year-over-year increase in revenue. Furthermore, Talkspace achieved a net income of $4.8 million for Q4 2025, a significant increase of 293% over the prior-year period, and adjusted EBITDA of $6.6 million, up from $2.7 million in Q4 2024. The company also provided an optimistic outlook for 2026, forecasting revenue between $275 million and $290 million and adjusted EBITDA in the range of $30 million to $35 million, implying 90% to 122% growth in adjusted EBITDA.
2. Significant Growth in Payor Revenue.
A core driver of Talkspace's performance was the substantial growth in its Payor business. Fourth-quarter 2025 Payor revenue increased by 41% year-over-year, contributing significantly to the overall revenue growth. For the full year 2025, Payor revenue increased 38%. This expansion is attributed to deeper payor integrations and increased completed Payor sessions, with the company now covering over 200 million lives through insurance and employer benefits.
Show more
Stock Movement Drivers
Fundamental Drivers
The 41.4% change in TALK stock from 11/30/2025 to 3/5/2026 was primarily driven by a 41.4% change in the company's P/E Multiple.| (LTM values as of) | 11302025 | 3052026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.38 | 4.78 | 41.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 215 | 215 | 0.0% |
| Net Income Margin (%) | 2.0% | 2.0% | 0.0% |
| P/E Multiple | 132.4 | 187.3 | 41.4% |
| Shares Outstanding (Mil) | 166 | 166 | 0.0% |
| Cumulative Contribution | 41.4% |
Market Drivers
11/30/2025 to 3/5/2026| Return | Correlation | |
|---|---|---|
| TALK | 41.4% | |
| Market (SPY) | -0.3% | 27.8% |
| Sector (XLV) | -2.4% | 6.4% |
Fundamental Drivers
The 79.7% change in TALK stock from 8/31/2025 to 3/5/2026 was primarily driven by a 39.8% change in the company's Net Income Margin (%).| (LTM values as of) | 8312025 | 3052026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.66 | 4.78 | 79.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 203 | 215 | 5.9% |
| Net Income Margin (%) | 1.4% | 2.0% | 39.8% |
| P/E Multiple | 155.5 | 187.3 | 20.4% |
| Shares Outstanding (Mil) | 168 | 166 | 0.8% |
| Cumulative Contribution | 79.7% |
Market Drivers
8/31/2025 to 3/5/2026| Return | Correlation | |
|---|---|---|
| TALK | 79.7% | |
| Market (SPY) | 5.9% | 17.9% |
| Sector (XLV) | 12.5% | 8.6% |
Fundamental Drivers
The 67.1% change in TALK stock from 2/28/2025 to 3/5/2026 was primarily driven by a 39.3% change in the company's P/S Multiple.| (LTM values as of) | 2282025 | 3052026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.86 | 4.78 | 67.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 181 | 215 | 18.4% |
| P/S Multiple | 2.7 | 3.7 | 39.3% |
| Shares Outstanding (Mil) | 168 | 166 | 1.3% |
| Cumulative Contribution | 67.1% |
Market Drivers
2/28/2025 to 3/5/2026| Return | Correlation | |
|---|---|---|
| TALK | 67.1% | |
| Market (SPY) | 15.7% | 34.6% |
| Sector (XLV) | 4.7% | 18.3% |
Fundamental Drivers
The 425.3% change in TALK stock from 2/28/2023 to 3/5/2026 was primarily driven by a 204.5% change in the company's P/S Multiple.| (LTM values as of) | 2282023 | 3052026 | Change |
|---|---|---|---|
| Stock Price ($) | 0.91 | 4.78 | 425.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 118 | 215 | 81.1% |
| P/S Multiple | 1.2 | 3.7 | 204.5% |
| Shares Outstanding (Mil) | 158 | 166 | -4.7% |
| Cumulative Contribution | 425.3% |
Market Drivers
2/28/2023 to 3/5/2026| Return | Correlation | |
|---|---|---|
| TALK | 425.3% | |
| Market (SPY) | 78.3% | 31.0% |
| Sector (XLV) | 26.7% | 15.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| TALK Return | -82% | -69% | 316% | 22% | 17% | 36% | -54% |
| Peers Return | -44% | -28% | 7% | -3% | -18% | 2% | -65% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 0% | 83% |
Monthly Win Rates [3] | |||||||
| TALK Win Rate | 8% | 42% | 75% | 42% | 67% | 100% | |
| Peers Win Rate | 31% | 47% | 50% | 42% | 38% | 47% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| TALK Max Drawdown | -83% | -70% | -4% | -35% | -27% | -3% | |
| Peers Max Drawdown | -52% | -51% | -28% | -50% | -38% | -26% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: TDOC, HIMS, AMWL, LFST, ACHC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/5/2026 (YTD)
How Low Can It Go
| Event | TALK | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -95.2% | -25.4% |
| % Gain to Breakeven | 1971.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -10.9% | -33.9% |
| % Gain to Breakeven | 12.2% | 51.3% |
| Time to Breakeven | 66 days | 148 days |
Compare to TDOC, HIMS, AMWL, LFST, ACHC
In The Past
Talkspace's stock fell -95.2% during the 2022 Inflation Shock from a high on 2/10/2021. A -95.2% loss requires a 1971.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Talkspace (TALK)
AI Analysis | Feedback
Here are 1-2 brief analogies for Talkspace:
- Uber for therapy: It connects users with licensed therapists through a digital platform for convenient mental health services, much like Uber connects riders with drivers.
- Netflix for mental health: It offers subscription-based access to a network of mental health professionals, providing convenient, on-demand therapeutic services similar to how Netflix provides on-demand entertainment.
AI Analysis | Feedback
- Online Therapy: Provides virtual access to licensed therapists for individual therapy sessions via text, audio, or live video.
- Online Psychiatry & Medication Management: Offers virtual consultations with psychiatrists or psychiatric nurse practitioners for evaluation, diagnosis, and prescription management.
- Employer & Health Plan Partnerships: Delivers mental healthcare solutions as a covered benefit for employees through their employers or for members through their health insurance plans.
AI Analysis | Feedback
Talkspace (TALK) primarily sells its virtual behavioral healthcare services to other companies, particularly within the healthcare and employer benefits sectors, which then offer Talkspace's services to their members or employees. While Talkspace also serves individuals directly, the "enterprise channel" (B2B) represents the majority of its revenue and is a key growth driver.
Major Customers (Companies Talkspace Sells To):
-
Health Plans and Insurers: These are major managed care organizations and health insurance providers that contract with Talkspace to integrate its services into their benefit offerings for plan members.
- Cigna (CI)
- Aetna (part of CVS Health, CVS)
- Optum (part of UnitedHealth Group, UNH)
- Magellan Health (part of Centene Corporation, CNC)
- Employers and Employee Assistance Programs (EAPs): Many companies and their EAP providers contract directly with Talkspace to offer mental health and wellness benefits to their employees as part of their corporate benefits packages.
- Educational Institutions: Colleges and universities partner with Talkspace to provide accessible mental health support services to their students.
Categories of Customers (Individuals Served Directly):
In addition to its B2B partnerships, Talkspace also serves individuals directly through its direct-to-consumer channel:
- Private Pay Individuals: People who subscribe to Talkspace services using their own funds, without going through an employer, health plan, or educational institution.
AI Analysis | Feedback
- Amazon Web Services (AWS), a subsidiary of Amazon.com, Inc. (NASDAQ: AMZN)
AI Analysis | Feedback
Jon R. Cohen, M.D., Chief Executive Officer
Dr. Jon R. Cohen possesses over 30 years of experience in the healthcare industry. Before his role at Talkspace, he was the Executive Chairman and CEO of BioReference Laboratories, where he developed and scaled Scarlet Health, a digital at-home blood draw solution. He also held significant positions as SVP and Chief Medical Officer at Quest Diagnostics and Chief Medical Officer at Northwell Health. Dr. Cohen has a proven track record in developing and scaling digital health and mobile health technology initiatives.
Ian Harris, Chief Financial Officer
Ian Harris is responsible for overseeing and leading all financial functions at Talkspace. Prior to joining Talkspace, he was a Partner at Hudson Executive Capital LP, an alternative investment firm, where he focused on investments in the healthcare, technology, and financial services sectors. Earlier in his career, Mr. Harris worked at Barclays Capital, advising healthcare companies on mergers and acquisitions and capital market activities. He also serves as a director for Cantaloupe and Liberated Syndication.
Natalie Cummins, Chief Business Officer
Natalie Cummins is a healthcare executive with 30 years of experience in leading the commercialization of products and services within the healthcare paradigm. As Chief Business Officer at Talkspace, she is responsible for the Direct-to-Enterprise (DTE) business and developing strategic partnerships. Her previous roles include President and Chief Strategy Officer at BioReference Laboratories, where she also served as Chief Commercial Officer during the COVID-19 pandemic.
Gil Margolin, Chief Technology Officer
Gil Margolin serves as the Chief Technology Officer for Talkspace.
Nikole Benders-Hadi, M.D., Chief Medical Officer
Dr. Nikole Benders-Hadi holds the position of Chief Medical Officer at Talkspace.
AI Analysis | Feedback
The key risks to Talkspace's business include:
- Regulatory and Compliance Risks: Talkspace operates in a heavily regulated healthcare industry subject to evolving laws and regulations, such as HIPAA and GDPR. Non-compliance or data breaches could lead to increased operational costs, restrictions on business operations, and significant liabilities.
- Ability to Maintain and Expand its Therapist Network: The company's growth strategy and ability to deliver services depend significantly on maintaining and expanding its network of licensed therapists, psychiatrists, and other providers. Challenges such as relatively low pay for therapists, potential for burnout, and issues with the independent contractor model could affect the quality, availability, and retention of its provider network, impacting service delivery.
- Intense Competition and Pricing Pressure: Talkspace faces significant competition within the virtual behavioral health market from both specialized providers and larger technology companies. This competitive landscape can lead to pricing pressures and a reduction in market share. Additionally, the company's reliance on a limited number of large customers for a substantial portion of its revenue, coupled with potential difficulties in raising prices with insurers, poses a risk to its financial stability and growth.
AI Analysis | Feedback
- The increasing saturation of the virtual mental health market has led to intense competition from numerous platforms (e.g., BetterHelp, Cerebral, Teladoc/Livongo, Amwell, Hims & Hers) vying for market share. This escalating competition drives up customer acquisition costs through aggressive marketing and pricing pressures, making it more challenging for Talkspace to grow its user base and maintain profitability without significant investment.
- Large employers and insurance payers are increasingly developing their own in-house virtual mental health solutions or establishing exclusive partnerships with specific providers. This trend reduces the addressable market for independent platforms like Talkspace, as major benefit providers opt for integrated, proprietary services rather than utilizing third-party networks.
- The rapid advancement and adoption of AI-powered mental health support tools and chatbots represent an emerging threat. While not a direct replacement for human therapy, these AI solutions can offer low-cost or free conversational support, coping strategies, and psychoeducation for individuals seeking less intensive interventions. This could divert a segment of potential users who might otherwise seek human-led therapy through platforms like Talkspace, particularly for lower-acuity needs.
AI Analysis | Feedback
Talkspace (TALK) operates within the burgeoning digital mental health and telehealth markets, offering online therapy, psychiatry services, and corporate wellness programs. The addressable markets for their main products and services are primarily within the United States, with some global market data available for broader categories.
Addressable Market Sizes:
- U.S. Digital Mental Health Market: This market, which encompasses Talkspace's core offerings, was valued at approximately $5.60 billion in 2024 and is projected to reach $47.72 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of 21.50% from 2025 to 2035. Other estimates suggest the market could reach $69.44 billion by 2030.
- U.S. Telehealth Market (including mental health services): The broader U.S. telehealth market was valued at $81 billion in 2024 and is projected to reach $395.6 billion by 2034, with a CAGR of 17.3%. Specifically, telepsychiatry is a leading application within this market, holding a 29.6% market share. The U.S. telehealth market was also valued at $42.61 billion in 2024 and is anticipated to increase to $52.76 billion in 2025, with a forecast to reach around $358.96 billion by 2034, growing at a CAGR of 23.84%.
- U.S. Virtual Mental Health Services Market: This segment was valued at $1.63 billion in 2022 and is poised for substantial growth, projected to reach $2.88 billion by 2028 with a CAGR of 10.09%.
- U.S. Behavioral Health Market: The U.S. behavioral health market is forecast to increase by $9.17 billion at a CAGR of 4.2% between 2024 and 2029, and is estimated to be $137 billion by 2032.
- U.S. Behavioral and Mental Health Software Market: This market was valued at $2.01 billion in 2024 and is projected to reach approximately $9.69 billion by 2034, growing at a CAGR of 17.03% from 2025 to 2034.
- Global Online Therapy Services Market: Globally, the online therapy services market was estimated at $9.68 billion in 2024 and is expected to surpass $24.80 billion by 2031, with a CAGR of 14.4%.
- U.S. Adolescent Mental Health Market: Talkspace estimates the total addressable market for adolescents to be over $500 million.
AI Analysis | Feedback
Talkspace (TALK) is expected to drive future revenue growth over the next 2-3 years through several key strategies:1. Continued Expansion of the Payer Business
Talkspace is heavily focused on expanding its partnerships with health insurers and Employee Assistance Programs (EAPs). The company has demonstrated substantial growth in its payer revenue, which increased by 42% year-over-year to $45.5 million in Q3 2025. This growth is fueled by a 29% increase in active payer members and a 37% rise in payer sessions during the same period. Strategic initiatives include launching with new "Blues plans" and securing competitive national EAP contracts, indicating a strong focus on integrating with existing healthcare networks. This expansion capitalizes on the growing trend of insurance coverage for mental health services.2. Strategic Product Enhancements and AI Integration
The company is investing in technology and product innovation, particularly in artificial intelligence (AI), to enhance its service offerings and improve patient engagement. Talkspace views its AI developments as a significant opportunity to provide superior handling of high-risk behavioral health scenarios. The integration of AI aims to improve customer engagement and session completion rates, with potential for varied monetization strategies across different populations. Additionally, the relaunch of its psychiatry business has shown strong results, with initial session volume increasing by 46% and the psychiatry provider network growing by nearly 50% from Q2 2025.3. Expansion into New Markets and Strategic Partnerships
Talkspace is broadening its reach by entering new market segments and forming high-value partnerships. The acquisition of Wisdo Health is intended to enhance its Medicare strategy, especially through group coaching and peer-to-peer support for seniors, which is expected to increase engagement. Furthermore, the partnership with Novo Nordisk for the WeGo Together app demonstrates an expansion into the pharmaceutical space, offering comprehensive mental health solutions integrated with technology for patient support. These alignments represent significant opportunities for new revenue streams.4. Growth in the Direct-to-Enterprise (DTE) Segment
While the payer business is the primary driver, Talkspace continues to pursue growth within its Direct-to-Enterprise (DTE) segment, which involves partnerships with employers. In Q4 2024, DTE revenue grew 7% year-over-year, with notable new launches including contracts with the City of Seattle and the U.S. Navy. Although DTE revenue experienced a slight decline in Q3 2025, the ongoing focus on employer partnerships as part of its broader B2B strategy indicates it remains a relevant growth driver.AI Analysis | Feedback
Share Repurchases
- Talkspace initiated a $15 million share repurchase program on February 22, 2024, set to run for two years.
- In August 2024, an additional $25 million share repurchase program was authorized, bringing the total aggregate authorized amount to $32 million remaining for future repurchases over 24 months.
- As of September 30, 2025, the company had repurchased $28.18 million worth of shares under the program announced in February 2024. In the third quarter of 2025 alone, $8.8 million of shares were repurchased, with $11.8 million remaining authorized for buybacks as of November 4, 2025.
Share Issuance
- In January 2021, Talkspace went public through a merger with the Special Purpose Acquisition Company (SPAC) Hudson Executive Investment Corp., which provided $250 million in growth capital.
- The SPAC merger included an oversubscribed Private Investment in Public Equity (PIPE) of $300 million at $10 per share.
- In March 2023, Talkspace sought to increase its authorized common stock from 401 million to 1 billion shares and authorized preferred stock to 100 million shares, totaling 1.1 billion authorized shares.
Inbound Investments
- The company's going-public transaction in January 2021 via a SPAC merger provided $250 million in cash.
- This transaction was significantly bolstered by a $300 million PIPE investment from institutional investors.
Outbound Investments
- In October 2025, Talkspace acquired Wisdo Health, a peer support and coaching platform, in a transaction that involved both cash and stock.
Capital Expenditures
- Capital expenditures were $0.663 million in 2021, $0.35 million in 2022, and $0.151 million in 2023.
- For 2024, estimated capital expenditures were projected to be between $3 million and $4 million, with a focus on technology and AI, operational efficiencies, and the product ecosystem for Direct-to-Enterprise (DTE) members. The projected CapEx for 2024 was $5.443 million.
- Expected capital expenditures for 2025 are $4.303 million, with continued investment in building foundational large language models for behavioral health.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Talkspace Earnings Notes | 12/16/2025 | |
| With Talkspace Stock Surging, Have You Considered The Downside? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to TALK.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | QDEL | QuidelOrtho | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | CHE | Chemed | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | LLY | Eli Lilly | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.0% | 0.0% | 0.0% |
| 02202026 | HAE | Haemonetics | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 3.5% | 3.5% | 0.0% |
| 02132026 | IQV | IQVIA | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 7.1% | 7.1% | -3.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 6.28 |
| Mkt Cap | 1.6 |
| Rev LTM | 1,886 |
| Op Inc LTM | 12 |
| FCF LTM | 28 |
| FCF 3Y Avg | 18 |
| CFO LTM | 139 |
| CFO 3Y Avg | 144 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 9.4% |
| Rev Chg 3Y Avg | 13.3% |
| Rev Chg Q | 11.8% |
| QoQ Delta Rev Chg LTM | 2.8% |
| Op Mgn LTM | 0.8% |
| Op Mgn 3Y Avg | -6.9% |
| QoQ Delta Op Mgn LTM | 0.6% |
| CFO/Rev LTM | 7.1% |
| CFO/Rev 3Y Avg | 6.9% |
| FCF/Rev LTM | 0.8% |
| FCF/Rev 3Y Avg | -1.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.6 |
| P/S | 1.1 |
| P/EBIT | -1.6 |
| P/E | 13.6 |
| P/CFO | 14.5 |
| Total Yield | -12.2% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | -0.3% |
| D/E | 0.2 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 9.4% |
| 3M Rtn | 21.9% |
| 6M Rtn | -6.1% |
| 12M Rtn | -26.4% |
| 3Y Rtn | -8.9% |
| 1M Excs Rtn | 10.7% |
| 3M Excs Rtn | 24.1% |
| 6M Excs Rtn | -12.8% |
| 12M Excs Rtn | -45.5% |
| 3Y Excs Rtn | -87.2% |
Price Behavior
| Market Price | $4.78 | |
| Market Cap ($ Bil) | 0.8 | |
| First Trading Date | 07/30/2020 | |
| Distance from 52W High | -4.2% | |
| 50 Days | 200 Days | |
| DMA Price | $4.06 | $3.17 |
| DMA Trend | up | up |
| Distance from DMA | 17.8% | 51.0% |
| 3M | 1YR | |
| Volatility | 64.0% | 54.5% |
| Downside Capture | -40.07 | 89.62 |
| Upside Capture | 221.83 | 131.05 |
| Correlation (SPY) | 26.7% | 34.7% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.56 | 1.80 | 1.69 | 0.83 | 0.98 | 1.21 |
| Up Beta | 0.82 | 1.28 | 1.67 | 0.35 | 0.99 | 0.98 |
| Down Beta | 7.65 | 4.36 | 3.58 | 1.31 | 0.95 | 1.33 |
| Up Capture | 159% | 231% | 223% | 180% | 140% | 404% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 12 | 23 | 32 | 63 | 125 | 368 |
| Down Capture | -145% | -57% | -27% | 1% | 86% | 103% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 9 | 18 | 28 | 56 | 116 | 350 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TALK | |
|---|---|---|---|---|
| TALK | 65.6% | 54.6% | 1.12 | - |
| Sector ETF (XLV) | 5.3% | 17.5% | 0.14 | 18.9% |
| Equity (SPY) | 19.2% | 19.1% | 0.79 | 34.9% |
| Gold (GLD) | 74.7% | 26.1% | 2.12 | -1.8% |
| Commodities (DBC) | 19.3% | 17.1% | 0.87 | 7.9% |
| Real Estate (VNQ) | 5.4% | 16.6% | 0.15 | 22.4% |
| Bitcoin (BTCUSD) | -16.6% | 45.6% | -0.26 | 21.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TALK | |
|---|---|---|---|---|
| TALK | -17.0% | 69.0% | 0.02 | - |
| Sector ETF (XLV) | 8.1% | 14.5% | 0.37 | 15.7% |
| Equity (SPY) | 13.9% | 17.0% | 0.65 | 28.1% |
| Gold (GLD) | 23.7% | 17.2% | 1.12 | 6.6% |
| Commodities (DBC) | 11.7% | 19.0% | 0.50 | 6.2% |
| Real Estate (VNQ) | 5.3% | 18.8% | 0.19 | 18.8% |
| Bitcoin (BTCUSD) | 9.5% | 56.9% | 0.38 | 15.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with TALK | |
|---|---|---|---|---|
| TALK | -8.4% | 66.3% | 0.04 | - |
| Sector ETF (XLV) | 10.4% | 16.5% | 0.52 | 15.3% |
| Equity (SPY) | 15.2% | 17.9% | 0.73 | 26.3% |
| Gold (GLD) | 14.8% | 15.6% | 0.79 | 6.3% |
| Commodities (DBC) | 9.0% | 17.6% | 0.43 | 5.7% |
| Real Estate (VNQ) | 6.2% | 20.7% | 0.26 | 16.9% |
| Bitcoin (BTCUSD) | 67.3% | 66.8% | 1.07 | 14.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/19/2026 | 22.9% | 15.5% | |
| 10/30/2025 | 4.7% | 24.2% | 13.0% |
| 8/5/2025 | -3.8% | 4.2% | 12.3% |
| 5/6/2025 | 0.5% | -1.6% | 5.6% |
| 2/20/2025 | -14.8% | -25.9% | -28.2% |
| 10/29/2024 | 18.2% | 16.4% | 23.0% |
| 8/6/2024 | -1.7% | -5.6% | 6.8% |
| 5/7/2024 | -15.4% | -10.4% | -16.4% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 9 | 12 |
| # Negative | 10 | 10 | 6 |
| Median Positive | 15.7% | 16.4% | 15.2% |
| Median Negative | -7.7% | -10.1% | -25.3% |
| Max Positive | 22.9% | 24.2% | 48.7% |
| Max Negative | -36.3% | -38.6% | -43.4% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-Q |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 03/12/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/13/2024 | 10-K |
| 09/30/2023 | 11/07/2023 | 10-Q |
| 06/30/2023 | 08/02/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/10/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/09/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
| 12/31/2021 | 02/25/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Margolin, Gil | Chief Technology Officer | Direct | Sell | 12152025 | 3.26 | 14,542 | 47,407 | 677,141 | Form |
| 2 | Margolin, Gil | Chief Technology Officer | Direct | Sell | 12022025 | 3.15 | 3,516 | 11,075 | 728,586 | Form |
| 3 | Margolin, Gil | Chief Technology Officer | Direct | Sell | 9122025 | 2.58 | 19,563 | 50,473 | 596,746 | Form |
| 4 | Margolin, Gil | Chief Technology Officer | Direct | Sell | 9032025 | 2.63 | 3,516 | 9,247 | 690,680 | Form |
| 5 | Margolin, Gil | Chief Technology Officer | Direct | Sell | 6172025 | 2.91 | 19,302 | 56,227 | 765,000 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.